Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The designation "No discrete host molecular target" is applied to pharmacological agents that do not interact with specific host proteins, such as receptors, enzymes, or transporters, to produce their therapeutic effects [1]. Instead, these substances rely on their intrinsic physical or chemical properties to alter the physiological environment. Common examples include antacids, which neutralize gastric acid through a simple chemical reaction, and osmotic laxatives or diuretics, which draw water into specific compartments via an osmotic gradient [2, 3]. This category also encompasses surfactants like simethicone, which change the surface tension of gas bubbles, and adsorbents like activated charcoal that physically trap toxins [1, 4]. Because these drugs do not target specific molecular pathways, their efficacy is typically dependent on their bulk concentration and physical presence rather than high-affinity binding [2]. Despite the lack of a specific protein target, these agents can still lead to significant systemic complications, particularly electrolyte imbalances or interference with the pharmacokinetics of other medications [1, 5]. Sources: [1] DrugBank Online (drugbank.com); [2] StatPearls, "Antacids" (ncbi.nlm.nih.gov/books/NBK526049/); [3] PubChem, "Mannitol" (pubchem.ncbi.nlm.nih.gov); [4] Merck Manual, "Adsorbents"; [5] Mayo Clinic, "Drug Interactions with Antacids".
Drugs in this category exert their effects through physical or chemical processes such as the chemical neutralization of acid, the creation of osmotic gradients to shift fluid, the physical adsorption of molecules, or the alteration of surface tension [1, 2].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No discrete host molecular target.